OneMedNet Corp (ONMD): who owns it and who trades it
As of Nov 16, 2026, ONMD insiders reported 6 open-market sales worth $177K and 14 purchases worth $4.2M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Aaron Green (CEO), with $122K.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, ONMD insiders reported $4.2M of open-market purchases and $177K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Jeffrey Yu | Director | Purchase | 45,126 | $5.54 | $250K | Form 4 |
| Oct 7, 2026 | Thomas Kosasa | Director | Purchase | 129,758 | $5.78 | $750K | Form 4 |
| Sep 24, 2026 | Aaron Green | CEO | Sale | 1,667 | $6.48 | $10.8K | Form 4 |
| Sep 22, 2026 | Aaron Green | CEO | Sale | 5,000 | $7.39 | $37K | Form 4 |
| Sep 21, 2026 | Robert Lawrence Golden | CFO | Sale | 3,000 | $6.63 | $19.9K | Form 4 |
| Sep 15, 2026 | Robert Lawrence Golden | CFO | Sale | 3,000 | $6.30 | $18.9K | Form 4 |
| Sep 14, 2026 | Robert Lawrence Golden | CFO | Sale | 2,500 | $6.60 | $16.5K | Form 4 |
| Sep 10, 2026 | Jeffrey Yu | Director | Purchase | 142,857 | $0.63 | $90K | Form 4 |
| Jul 30, 2026 | Thomas Kosasa | Director | Purchase | 1.45M | $0.69 | $1000K | Form 4 |
| Jun 23, 2026 | Aaron Green | CEO | Purchase | 36,650 | $0.57 | $20.9K | Form 4 |
| Jun 23, 2026 | Jeffrey Yu | Director | Purchase | 158,730 | $0.63 | $100K | Form 4 |
| Jun 16, 2026 | Jeffrey Yu | Director | Purchase | 172,414 | $0.58 | $100K | Form 4 |
| Jun 15, 2026 | Aaron Green | CEO | Purchase | 18,702 | $0.54 | $10.1K | Form 4 |
| Jun 12, 2026 | Aaron Green | CEO | Purchase | 36,920 | $0.56 | $20.7K | Form 4 |
| Jun 12, 2026 | Thomas Kosasa | Director | Purchase | 158,730 | $0.63 | $100K | Form 4 |
| May 18, 2026 | Thomas Kosasa | Director | Purchase | 268,817 | $0.93 | $250K | Form 4 |
| Apr 23, 2026 | Thomas Kosasa | Director | Purchase | 280,898 | $0.89 | $250K | Form 4 |
| Apr 1, 2026 | Jeffrey Yu | Director | Purchase | 903,614 | $0.83 | $750K | Form 4 |
| Feb 6, 2026 | Thomas Kosasa | Director | Purchase | 595,238 | $0.84 | $500K | Form 4 |
| Nov 18, 2025 | Aaron Green | CEO | Sale | 61,555 | $1.20 | $73.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Thomas Kosasa | Director, 10% owner | $2.8M | – | Oct 7, 2026 |
| Jeffrey Yu | Chief Medical Officer, Director, 10% owner | $1.3M | – | Oct 9, 2026 |
| Aaron Green | Chief Executive Officer, Director | $51.7K | $122K | Sep 24, 2026 |
| Robert Lawrence Golden | Chief Financial Officer, Director | – | $55.3K | Sep 21, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ONMD short interest
133,071 ONMD shares are sold short. Over the last 12 reports the number of shares short went up 139%.
As of Oct 30, 2026, 133,071 ONMD shares were sold short, down 11.9% from the report before. At the average daily volume of 23,066 shares, buying them all back would take about 5.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 133,071 | – | -12% | 23,066 | 5.8 |
| Oct 15, 2026 | 151,048 | – | +33% | 43,439 | 3.5 |
| Sep 30, 2026 | 113,555 | – | +23% | 94,253 | 1.2 |
| Sep 15, 2026 | 922,431 | – | +5% | 198,376 | 4.7 |
| Aug 31, 2026 | 87,657 | 1.48% | +21% | 342,431 | 2.6 |
| Aug 14, 2026 | 72,182 | 1.22% | -60% | 666,106 | 1.1 |
| Jul 31, 2026 | 181,622 | 3.48% | +426% | 3.84M | 1.0 |
| Jul 15, 2026 | 34,550 | 0.66% | +48% | 125,694 | 2.8 |
| Jun 30, 2026 | 23,282 | 0.45% | -54% | 501,081 | 1.0 |
| Jun 15, 2026 | 50,824 | 0.97% | +11% | 317,044 | 1.6 |
| May 29, 2026 | 45,729 | 0.88% | -18% | 278,774 | 1.6 |
| May 15, 2026 | 55,759 | 1.07% | -25% | 311,808 | 1.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
OneMedNet company events
OneMedNet filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Nov 9, 2026.
- Nov 9, 2026ResultsReleased financial results. Filing
- Nov 6, 2026ResultsReleased financial results. Filing
- Oct 14, 2026AnnouncementAs previously disclosed, on April 14, 2026, OneMedNet Corporation received a letter from the staff of the Listing Qualifications department of The Nasdaq Stock Market notifying the Company that it was not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq… Filing
- Sep 29, 2026SharesChanged the rights of its shareholders. Filing
- Sep 23, 2026LeadershipOneMedNet Corporation held its 2026 Annual Meeting of Stockholders as a virtual meeting online via live audio webcast, at which the Company’s stockholders approved an amendment and restatement of the OneMedNet Corporation Amended and Restated 2022 Equity Incentive Plan (as amended and restated, the… Filing
- Jul 24, 2026AnnouncementOf this Current Report on Form 8-K is incorporated by reference into this Item 5.08. Filing
- Jul 1, 2026AgreementOneMedNet Corporation, a Delaware corporation entered into a standby equity purchase agreement with YA II PN, Ltd., a Cayman Islands exempt limited partnership. Filing
- Apr 20, 2026ListingOneMedNet Corporation received notice from the staff of the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the… Filing
- Dec 23, 2025AnnouncementThe Board of Directors of the Company appointed Dr. Kenneth Alleyne to serve as a member of the Compensation Committee of the Board in place of Jair Clarke, whose term on the Board expired at the Annual Meeting. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
OneMedNet financials
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named ONMD in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Off the Chain LP | 13G/A | 0.5% |
| Nov 16, 2026 | Off the Chain LP | 13G/A | 0.5% |
| Nov 13, 2026 | TD SECURITIES (USA) LLC | 13G/A | 4.6% |
| Nov 13, 2026 | TD SECURITIES (USA) LLC | 13G/A | 4.6% |
Questions about OneMedNet Corp (ONMD) stock
Are ONMD insiders buying or selling?
In the last 12 months, ONMD insiders reported 14 open-market purchases worth $4.2M and 6 sales worth $177K. The latest trade was on Oct 9, 2026. See every trade.
What is the short interest in ONMD?
As of Oct 30, 2026, 133,071 ONMD shares were sold short, down 11.9% from the report before. At the average daily volume of 23,066 shares, buying them all back would take about 5.8 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.